|
OVERVIEW
Management of dystonia and spasticity aims to improve activities of daily living by improving mobility, reducing muscle tone, providing pain relief, and prevention of contractures. The emphasis on dystonia and spasticity in training curricula for neurology and physical medicine as well as rehabilitation residents and fellows is variable, with important aspects often lacking. For example, very few residents and fellows receive any supervised training in the appropriate use and administration of chemodenervation agents.
A critical review of the literature, clinical trial data, and understanding of distinctions between botulinum neurotoxins is essential to appropriately treat and manage patients with dystonia and spasticity, as is hands-on injection training.
This complementary workshop, popular in previous years, is offered again in 2010 and will provide residents fellows with a unique opportunity to improve their knowledge and competence in treating patients with dystonia and spasticity. The workshop curriculum includes interactive, evidence-based presentations and dynamic hands-on injection training, as demonstrated by our expert faculty on actual dystonia and spasticity patients.
Return to Top
GOAL
The purpose of the Fourth Annual Johns Hopkins Dystonia and Spasticity Practicum will be to educate residents and fellows in neurology and physical medicine and rehabilitation, community neurologists, physiatrists, and physical and occupational therapists on the science and clinical issues related to the management of patients with dystonia and spasticity. This educational activity seeks to provide residents and fellows in neurology and physical medicine and rehabilitation, community neurologists, physiatrists, and physical and occupational therapists with in-depth, evidence-based education that includes hands-on experience in treating patients with dystonia and spasticity.
Return to Top
INTENDED AUDIENCE
This activity is designed for residents and fellows in neurology and physical medicine and rehabilitation, community neurologists, physiatrists, and physical and occupational therapists. No prerequisites required.
Return to Top
AGENDA
8:30 – 9:00 AM |
Registration and Breakfast |
9:00 – 9:25 AM |
Conference Goals and Pre-Assessment
Zoltan Mari, MD |
9:25 – 10:10 AM |
Dystonia: Introduction and Overview
Daniel Tarsy, MD |
10:10 – 10:20 AM |
Question and Answer Session |
10:20 – 11:05 AM |
Spasticity: Introduction and Overview
R. Samuel Mayer, MD |
11:05 – 11:15 AM |
Question and Answer Session
|
11:15 – 11:20 AM |
Break
|
11:20 – 12:05 PM |
Chemodenervation: Basics and Practical Considerations
Barbara I. Karp, MD
|
12:05 – 12:15 PM |
Question and Answer Session
|
12:15 – 1:00 PM |
Lunch: Reflection/Discussion with Faculty
|
1:00 – 3:00 PM |
Breakout Sessions: Injection Training Workshops
- Models (ELVIS/ELVIRA)
Barbara I. Karp, MD and Daniel Tarsy, MD
- Dystonia – Live Patients
Zoltan Mari, MD
- Spasticity – Live Patients
R. Samuel Mayer, MD
|
3:00 – 3:15 PM |
Educational Outcomes Activity
Faith H. Howarth, MSN, EdM, CRNP, CS
|
3:15 – 3:30 PM |
Concluding Remarks and Post-Assessment
Zoltan Mari, MD
|
Return to Top
ADVISORY BOARD
CHAIRPERSON
Zoltan Mari, MD
Assistant Professor
Department of Neurology
Johns Hopkins University School of Medicine
PARTICIPATING FACULTY
Cynthia L. Comella, MD
Professor
Department of Neurological Sciences
Rush University Medical Center
Barbara I. Karp, MD
Combined NeuroScience Institutional Review Boards
National Institute of Neurological Disorders and Stroke
National Institutes of Health
R. Samuel Mayer, MD
Assistant Professor
Vice Chair for Education
Department of Physical Medicine and Rehabilitation
Johns Hopkins University School of Medicine
Deputy Director, Quality Improvement
Department of Physical Medicine and Rehabilitation, The Johns Hopkins Hospital
Daniel Tarsy, MD
Professor in Neurology
Harvard Medical School
Director, Parkinson’s Disease & Movement Disorders Center
Beth Israel Deaconess Medical Center
Return to Top
LEARNING OBJECTIVES
At the conclusion of this activity, participants should be able to:
- EVALUATE patients with dystonia or spasticity and
compare/contrast available evidenced-based treatments.
- DESCRIBE the clinically relevant distinctions between botulinum toxins A and B by a review of clinical trial data, and identify those patients most appropriately
treated with each toxin.
- DEMONSTRATE proficiency in the administration of chemodenervation
treatment for spasticity and dystonia.
The Johns Hopkins University School of Medicine takes
responsibility for the content, quality, and scientific integrity
of this CME activity.
Return to Top
CME INFORMATION
Accreditation Statement — The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement — The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure — It is the policy of the Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosures will be made in the course handout materials.
Americans with Disabilities Act (ADA) — The Johns Hopkins University School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.
Fee Information — There is no fee for this educational activity
Return to Top
|
